Drug
BMS-955176 clinical trials
Also written BMS-955176.
- studies test it
- 10
- open now
- 0
- in phase 3
- 0
- first study started
- 2013
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
10 studies that test it; most in 2014 (4)
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2014 | 4 |
| 2015 | 3 |
| 2016 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 7
- Phase 2
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses BMS-955176 is read from its arms, and is right about nine times in ten.
Testing it · 10
- Study to Evaluate a HIV Drug for the Treatment of HIV InfectionCompletedPhase 2ViiV HealthcareNCT01803074Written as BMS-955176
- Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive AdultsTerminatedPhase 2ViiV HealthcareNCT02415595Written as BMS-955176
- Strategy-confirming Study of BMS-955176 to Treat HIV-1 Infected Treatment-experienced AdultsTerminatedPhase 2ViiV HealthcareNCT02386098Written as BMS-955176
- Study on Effects of BMS-955176 on the Pharmacokinetics of Probe SubstratesCompletedPhase 1ViiV HealthcareNCT02578277Written as BMS-955176
- Study of Combined Oral Contraceptive Effects in Female SubjectsCompletedPhase 1ViiV HealthcareNCT02157467Written as BMS-955176
- Taste Properties of HIV InhibitorCompletedPhase 1ViiV HealthcareNCT02608918Written as BMS-955176
- Study of the Absorption, Metabolism, and Route of Elimination of a Novel Class of Anti-HIV 1 Drugs (BMS-955176) in Humans.CompletedPhase 1ViiV HealthcareNCT02206711Written as BMS-955176
- Relative Bioavailability Study With BMS-955176CompletedPhase 1ViiV HealthcareNCT02095886Written as BMS-955176
- Food Effect Study With BMS-955176CompletedPhase 1ViiV HealthcareNCT02273947Written as BMS-955176
- A Study to Evaluate the Effect of BMS-955176 on Pharmacokinetics of Dolutegravir and the Effect of Dolutegravir on the Pharmacokinetics of BMS-955176CompletedPhase 1ViiV HealthcareNCT02715479Written as BMS955176
Codes
What other systems call BMS-955176 · ClinicalTrials.gg INT000947
- MeSH (NLM) C000627567BMS-955176Confirmed ClinicalTrials.gov, NLM
- UNII (FDA) 4CA9IAU7RJBMS-955176Confirmed NLM, Wikidata
- Wikidata Q24975505BMS-955176Confirmed NLM, Wikidata
- DrugBank DB15193One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000627567 | BMS-955176 | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 4CA9IAU7RJ | BMS-955176 | Confirmed NLM, Wikidata |
| Wikidata | Q24975505 | BMS-955176 | Confirmed NLM, Wikidata |
| DrugBank | DB15193 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.